Literature DB >> 16606331

Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress.

Helmut K Seitz1, Felix Stickel.   

Abstract

Hepatocellular cancer is the fifth most frequent cancer in men and the eighth in women worldwide. Established risk factors are chronic hepatitis B and C infection, chronic heavy alcohol consumption, obesity and type 2 diabetes, tobacco use, use of oral contraceptives, and aflatoxin-contaminated food. Almost 90% of all hepatocellular carcinomas develop in cirrhotic livers. In Western countries, attributable risks are highest for cirrhosis due to chronic alcohol abuse and viral hepatitis B and C infection. Among those with alcoholic cirrhosis, the annual incidence of hepatocellular cancer is 1-2%. An important mechanism implicated in alcohol-related hepatocarcinogenesis is oxidative stress from alcohol metabolism, inflammation, and increased iron storage. Ethanol-induced cytochrome P-450 2E1 produces various reactive oxygen species, leading to the formation of lipid peroxides such as 4-hydroxy-nonenal. Furthermore, alcohol impairs the antioxidant defense system, resulting in mitochondrial damage and apoptosis. Chronic alcohol exposure elicits hepatocyte hyperregeneration due to the activation of survival factors and interference with retinoid metabolism. Direct DNA damage results from acetaldehyde, which can bind to DNA, inhibit DNA repair systems, and lead to the formation of carcinogenic exocyclic DNA etheno adducts. Finally, chronic alcohol abuse interferes with methyl group transfer and may thereby alter gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606331     DOI: 10.1515/BC.2006.047

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  99 in total

Review 1.  Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).

Authors:  Monica Lupsor-Platon; Radu Badea
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 2.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

Review 3.  From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence.

Authors:  Gayatri Ramakrishna; Archana Rastogi; Nirupama Trehanpati; Bijoya Sen; Ritu Khosla; Shiv K Sarin
Journal:  Liver Cancer       Date:  2013-08       Impact factor: 11.740

4.  GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population.

Authors:  Lei Yu; Chun-Yu Wang; Bo Xi; Lei Sun; Ruo-Qi Wang; Yin-Kun Yan; Li-Ying Zhu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 5.  Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.

Authors:  Adam S Bodzin; Ronald W Busuttil
Journal:  World J Hepatol       Date:  2015-05-28

Review 6.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

7.  Health behaviors of Korean adults with hepatitis B: Findings of the 2016 Korean National Health and Nutrition Examination Survey.

Authors:  Yu-Hyeon Yi; Yun-Jin Kim; Sang-Yeoup Lee; Byung-Mann Cho; Young-Hye Cho; Jeong-Gyu Lee
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

8.  Effect of alcohol consumption on liver stiffness measured by transient elastography.

Authors:  Edouard Bardou-Jacquet; Ludivine Legros; Draman Soro; Marianne Latournerie; Anne Guillygomarc'h; Caroline Le Lan; Pierre Brissot; Dominique Guyader; Romain Moirand
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 9.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

Review 10.  Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

Authors:  Virginia Hernandez-Gea; Fanny Turon; Annalisa Berzigotti; Augusto Villanueva
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.